Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy-Reference-Cited by-全球学者库

Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy

Published:2020 Issue:10 Volume:8 Page:2939-2954
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Ahir Manisha¹²³⁴⁵,Upadhyay Priyanka¹²³⁴⁵,Ghosh Avijit¹²³⁴⁵,Sarker Sushmita¹²³⁴⁵,Bhattacharya Saurav¹²³⁴⁵,Gupta Payal⁶³⁷⁵,Ghosh Swatilekha⁸⁹⁷⁷⁵,Chattopadhyay Sreya⁶³⁷⁵,Adhikary Arghya¹²³⁴⁵^ORCID

Affiliation:

1. Center for Research in Nanoscience and Nanotechnology

2. Technology Campus

3. University of Calcutta

4. Kolkata 700106

5. India

6. Department of Physiology

7. Kolkata

8. Amity School of Biotechnology

9. Amity University

Abstract

Cationic Mesoporous silica Nanoparticle coated with hyaluronic acid conjugated polymer (HA-Dual miRNA Np) facilitated enhanced dual miRNA loading, efficient delivery and significantly inhibited tumor growth as well as retarded metastasis in triple-negative breast cancer.

Funder

Department of Science and Technology

Council of Scientific and Industrial Research

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/D0BM00015A

Reference46 articles.

1. Estrogen receptor-beta is a potential target for triple negative breast cancer treatment

2. Triple-Negative Breast Cancer